Antimicrobial Agents Practice Questions

Q: A 25-year-old male university student presented with a history of multiple tick bites 45 days prior, followed by recurring episodes of high-grade fever, headache, myalgias, arthralgias, nausea, and occasional vomiting. Each episode lasted approximately 6-7 days with symptom-free intervals of 9-10 days. Physical examination revealed mild splenomegaly and skin lesions. A Wright stain of the patient's peripheral blood smear was performed. What is the first oral drug of choice for this patient?

Doxycycline. ***Doxycycline*** - The patient's presentation is classic for **tick-borne relapsing fever (TBRF)** caused by *Borrelia* species. - The **pathognomonic feature** is the **relapsing pattern**: recurring fever episodes (6-7 days) separated by **afebrile intervals** (9-10 days), which distinguishes TBRF from Lyme disease. - **Wright stain of peripheral blood smear** during febrile episodes typically reveals **spirochetes** (unlike Lyme disease where spirochetes are rarely visible in blood). - **Doxycycline 100 mg twice daily** is the **first-line oral treatment** for TBRF, with excellent activity against *Borrelia* spirochetes. - Also covers potential tick-borne coinfections (Ehrlichia, Anaplasma). *Amoxicillin* - While effective for **Lyme disease**, amoxicillin is **less effective for TBRF** compared to tetracyclines. - Used as an alternative in **pregnant women or children <8 years** when doxycycline is contraindicated. - Does not cover rickettsial coinfections that doxycycline would treat. *Cefuroxime* - This **second-generation cephalosporin** can be used as an alternative for Lyme disease. - However, it is **not the first-line choice** for the relapsing fever pattern seen in this case. - Doxycycline remains superior due to broader coverage and better efficacy for TBRF. *Erythromycin* - **Erythromycin** has **poor efficacy** against *Borrelia* species and is **not recommended** for TBRF or Lyme disease. - Higher relapse rates and treatment failures make it an inappropriate choice. - Modern macrolides (azithromycin) have better activity but still inferior to doxycycline.

Q: DEC (diethylcarbamazine) is used for the treatment of:

Filariasis (Wuchereria bancrofti and Brugia malayi). ***Filariasis (Wuchereria bancrofti and Brugia malayi)*** - **Diethylcarbamazine (DEC)** is the drug of choice for treating **lymphatic filariasis** caused by *Wuchereria bancrofti* and *Brugia malayi*. - DEC works by killing the **microfilariae** and adult worms in the lymphatic system. *Dracunculiasis (Dracunculus medinensis)* - Treatment for **dracunculiasis** primarily involves mechanical removal of the worm by winding it around a stick, with supportive care like analgesics and antibiotics for secondary infections. - DEC is **ineffective** against *Dracunculus medinensis*. *Schistosomiasis (Schistosoma species)* - The standard treatment for all forms of **schistosomiasis** is **praziquantel**. - DEC has **no significant efficacy** against *Schistosoma* species. *Taeniasis (Taenia species)* - **Taeniasis**, caused by tapeworms like *Taenia saginata* and *Taenia solium*, is effectively treated with **praziquantel** or **niclosamide**. - DEC is **not indicated** for the treatment of tapeworm infections.

Q: Which of the following drugs is an antipseudomonal penicillin?

Piperacillin. ***Piperacillin*** - **Piperacillin** is a broad-spectrum **antipseudomonal penicillin** (ureidopenicillin) that has significant activity against **Pseudomonas aeruginosa** due to modifications in its side chains. - It works by inhibiting bacterial cell wall synthesis and is often combined with a beta-lactamase inhibitor like **tazobactam** to broaden its spectrum further and overcome resistance. *Amoxicillin* - **Amoxicillin** is an **aminopenicillin** with a broader spectrum than natural penicillins, covering many gram-positive and gram-negative bacteria. - However, it **lacks antipseudomonal activity** and is not effective against **Pseudomonas aeruginosa**. - It does not have the structural modifications required for activity against Pseudomonas species. *Dicloxacillin* - **Dicloxacillin** is an **anti-staphylococcal penicillin** (penicillinase-resistant penicillin) primarily used for infections caused by methicillin-susceptible *Staphylococcus aureus*. - It does not have significant activity against **Pseudomonas aeruginosa** or other gram-negative organisms. *Cloxacillin* - **Cloxacillin** is similar to dicloxacillin, belonging to the **penicillinase-resistant penicillins**, and is used to treat infections caused by *Staphylococcus aureus*. - It lacks the necessary structural modifications to be effective against **Pseudomonas aeruginosa**.

Q: In the treatment of superficial bacterial skin infections, what is the standard concentration of tetracycline ointment typically prescribed for topical application?

1%. ***1%*** - **Tetracycline 1% ointment** is the standard and effective concentration for topical application in superficial bacterial skin infections [1]. - This concentration ensures adequate therapeutic levels of the antibiotic at the site of infection while minimizing systemic absorption. *0.10%* - A concentration of **0.10% tetracycline** is generally too low to be effective against most common bacterial skin infections. - This insufficient concentration could lead to treatment failure and potentially contribute to antibiotic resistance. *0.50%* - While higher than 0.10%, **0.50% tetracycline** is still considered a suboptimal concentration for treating superficial bacterial skin infections. - It might not achieve the necessary bactericidal or bacteriostatic effects required for successful eradication of the infection. *5%* - A **5% concentration of tetracycline** is typically too high for topical application and could increase the risk of local irritation or sensitization. - While potentially more potent, it is not the standard and usually offers no significant therapeutic advantage over the 1% concentration for superficial infections, while increasing potential side effects.

Q: What is an example of an entry inhibitor?

Enfuvirtide. ***Enfuvirtide*** - **Enfuvirtide** is a **fusion inhibitor** that blocks **HIV-1** from entering target cells by binding to the gp41 subunit of the viral envelope glycoprotein. - It works by preventing the conformational change in gp41 required for fusion of the viral and cellular membranes. *Abacavir* - **Abacavir** is a **nucleoside reverse transcriptase inhibitor (NRTI)**. - NRTIs incorporate into the growing viral DNA chain, causing chain termination and preventing viral replication. *Etravirine* - **Etravirine** is a **non-nucleoside reverse transcriptase inhibitor (NNRTI)**. - NNRTIs bind directly to the reverse transcriptase enzyme, altering its structure and inhibiting its function. *Amprenavir* - **Amprenavir** is a **protease inhibitor (PI)**. - Protease inhibitors prevent the cleavage of viral polyproteins into functional proteins, which is essential for the assembly of new infectious virions.

Q: Which one of the following statements is false regarding the use of adefovir dipivoxil?

It is used as a first-line treatment for HIV.. ***It is used as a first-line treatment for HIV.*** - **Adefovir dipivoxil** is primarily indicated for the treatment of **chronic hepatitis B** infection, not HIV [1]. - While it has some *in vitro* activity against HIV, it is **not recommended** for HIV treatment due to its suboptimal efficacy and potential for **nephrotoxicity** at the higher doses required for HIV [2]. *It is generally well tolerated when taken orally.* - **Adefovir dipivoxil** is indeed generally **well-tolerated** at the doses used for hepatitis B, with common side effects being mild and transient [2]. - However, **higher doses** can lead to significant **nephrotoxicity**, which is why it's not preferred for HIV treatment [2]. *It is an acyclic nucleotide analogue.* - **Adefovir dipivoxil** is a **prodrug** of adefovir, which is an **acyclic nucleotide analogue** (specifically, an adenosine monophosphate analogue) [1]. - This structure allows it to mimic natural nucleotides and interfere with **viral reverse transcriptase** or **DNA polymerase** [1]. *It is effective in treating chronic hepatitis B infection.* - **Adefovir dipivoxil** is an **antiviral medication** specifically approved and effective in treating **chronic hepatitis B virus (HBV) infection** [1]. - It works by inhibiting HBV DNA polymerase, thereby reducing **viral replication** [1].

Q: The multidrug regimen under the National Leprosy Eradication Programme for the treatment of all multibacillary leprosy would include which medications?

Clofazimine, rifampicin, and dapsone. ***Clofazimine, rifampicin, and dapsone*** - The standard multidrug therapy (MDT) for **multibacillary (MB) leprosy** under the National Leprosy Eradication Programme (NLEP) includes **rifampicin**, **dapsone**, and **clofazimine** [1], [2]. - This combination is crucial for effective treatment, preventing drug resistance, and minimizing relapse rates over a 12-month course [1]. *Rifampicin and dapsone* - This combination alone is typically used for **paucibacillary (PB) leprosy**, which involves fewer skin lesions and bacilli. - It lacks **clofazimine**, which is essential for adequate coverage and efficacy against the higher bacterial load seen in multibacillary leprosy [1]. *Ethionamide, rifampicin, and dapsone* - **Ethionamide** is primarily an antitubercular drug and is not part of the standard first-line regimen for leprosy [3]. - Its inclusion would be considered an off-label use or reserved for specific circumstances like **drug-resistant leprosy**, which is not the general case for all multibacillary leprosy. *Propionamide, rifampicin, and dapsone* - **Propionamide** is not a drug used in the treatment of leprosy. - This option introduces an incorrect and clinically irrelevant drug into the regimen.

Q: According to WHO guidelines for community health workers, which drug is commonly used in the management of acute respiratory infections?

Cotrimoxazole. ***Cotrimoxazole*** - **Cotrimoxazole (trimethoprim-sulfamethoxazole)** was historically recommended by WHO for community health workers in resource-limited settings for the treatment of **acute respiratory infections (ARIs)**. - It is effective against common bacterial pathogens causing ARIs, such as *Streptococcus pneumoniae* and *Haemophilus influenzae*. - **Note:** Current WHO IMCI (Integrated Management of Childhood Illness) guidelines now recommend **amoxicillin** as first-line treatment for pneumonia in children, though cotrimoxazole remains an alternative in specific contexts or where amoxicillin is unavailable. *Chloramphenicol* - **Chloramphenicol** is a potent broad-spectrum antibiotic but is generally reserved for severe infections due to potential side effects like **bone marrow suppression** (aplastic anemia). - It is not a first-line drug for routine community-level management of uncomplicated ARIs according to WHO guidelines. *Benzyl penicillin* - **Benzyl penicillin** (Penicillin G) is effective against many streptococcal infections but has a narrower spectrum compared to cotrimoxazole. - Its use in the community setting for ARIs is limited due to the need for **parenteral administration**, making it impractical for community health workers managing outpatient cases. *Gentamycin* - **Gentamycin** is an aminoglycoside antibiotic primarily used for severe Gram-negative bacterial infections, often in hospital settings. - It is administered parenterally and is not recommended by WHO for routine community-based treatment of ARIs due to the risk of **nephrotoxicity** and **ototoxicity**, and its limited effectiveness against common ARI pathogens.

Q: Ketoconazole is useful in all except:

T. capitis. ***T. capitis*** - **Ketoconazole** is generally not considered the first-line or most effective treatment for **Tinea capitis** due to its poor penetration into hair follicles. - **Oral griseofulvin** or **terbinafine** are preferred systemic antifungals for **Tinea capitis** because they can reach the infected hair shafts more effectively. *T. cruris* - **Ketoconazole** is an effective antifungal for **Tinea cruris**, which is a fungal infection of the groin, as it can be applied topically. - Its broad-spectrum antifungal activity makes it suitable for treating various superficial dermatophyte infections. *T. versicolor* - **Ketoconazole** is highly effective in treating **Tinea versicolor** (also known as Pityriasis versicolor), a superficial fungal infection caused by *Malassezia* species. - It can be used both topically (shampoo, cream) and orally to reduce the fungal burden. *T. corporis* - **Ketoconazole** is an appropriate topical antifungal agent for **Tinea corporis**, commonly known as ringworm of the body. - Its ability to inhibit ergosterol synthesis makes it effective against the dermatophytes responsible for this infection.

Q: Which species of Plasmodium is known for its common resistance to chloroquine?

Plasmodium falciparum. ***Plasmodium falciparum*** - **Plasmodium falciparum** is the species most commonly associated with severe malaria and has widespread resistance to **chloroquine**, primarily due to mutations in the **PfCRT** (_P. falciparum_ chloroquine resistance transporter) gene - Due to its high morbidity and mortality and the prevalence of **chloroquine resistance**, it often necessitates treatment with **artemisinin-based combination therapies (ACTs)** - Resistance is particularly widespread in sub-Saharan Africa, Southeast Asia, and South America *Plasmodium vivax* - While **P. vivax** resistance to chloroquine is emerging in some regions (Papua New Guinea, Indonesia), it is not as widespread or well-established globally as it is with **P. falciparum** - **P. vivax** is known for forming **hypnozoites** in the liver, requiring primaquine to prevent relapses, a feature not directly related to chloroquine resistance *Plasmodium malariae* - **P. malariae** primarily causes a milder form of malaria and remains largely susceptible to **chloroquine** - It is known for its relatively long incubation period and potential to cause **nephrotic syndrome** *Plasmodium ovale* - **P. ovale** is rare and generally confined to specific regions in West Africa, and like **P. malariae**, it remains largely susceptible to **chloroquine** - Similar to **P. vivax**, it forms **hypnozoites** in the liver, which can lead to relapses if not treated with primaquine

Question 1

A 25-year-old male university student presented with a history of multiple tick bites 45 days prior, followed by recurring episodes of high-grade fever, headache, myalgias, arthralgias, nausea, and occasional vomiting. Each episode lasted approximately 6-7 days with symptom-free intervals of 9-10 days. Physical examination revealed mild splenomegaly and skin lesions. A Wright stain of the patient's peripheral blood smear was performed. What is the first oral drug of choice for this patient?

Accepted Answer

Doxycycline

Answer

Amoxicillin

Answer

Cefuroxime

Answer

Erythromycin

Question 2

DEC (diethylcarbamazine) is used for the treatment of:

Accepted Answer

Filariasis (Wuchereria bancrofti and Brugia malayi)

Answer

Dracunculiasis (Dracunculus medinensis)

Answer

Schistosomiasis (Schistosoma species)

Answer

Taeniasis (Taenia species)

Question 3

Which of the following drugs is an antipseudomonal penicillin?

Accepted Answer

Piperacillin

Answer

Amoxicillin

Answer

Dicloxacillin

Answer

Cloxacillin

Question 4

In the treatment of superficial bacterial skin infections, what is the standard concentration of tetracycline ointment typically prescribed for topical application?

Accepted Answer

1%

Answer

0.10%

Answer

0.50%

Answer

5%

Question 5

What is an example of an entry inhibitor?

Accepted Answer

Enfuvirtide

Answer

Abacavir

Answer

Amprenavir

Answer

Etravirine

Question 6

Which one of the following statements is false regarding the use of adefovir dipivoxil?

Accepted Answer

It is used as a first-line treatment for HIV.

Answer

It is generally well tolerated when taken orally.

Answer

It is an acyclic nucleotide analogue.

Answer

It is effective in treating chronic hepatitis B infection.

Question 7

The multidrug regimen under the National Leprosy Eradication Programme for the treatment of all multibacillary leprosy would include which medications?

Accepted Answer

Clofazimine, rifampicin, and dapsone

Answer

Rifampicin and dapsone

Answer

Ethionamide, rifampicin, and dapsone

Answer

Propionamide, rifampicin, and dapsone

Question 8

According to WHO guidelines for community health workers, which drug is commonly used in the management of acute respiratory infections?

Accepted Answer

Cotrimoxazole

Answer

Chloramphenicol

Answer

Benzyl penicillin

Answer

Gentamycin

Question 9

Ketoconazole is useful in all except:

Accepted Answer

T. capitis

Answer

T. cruris

Answer

T. versicolor

Answer

T. corporis

Question 10

Which species of Plasmodium is known for its common resistance to chloroquine?

Accepted Answer

Plasmodium falciparum

Answer

Plasmodium vivax

Answer

Plasmodium malariae

Answer

Plasmodium ovale

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?